Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Homeodomain Expression in AML and T-ALL Cell Lines.

View through CrossRef
Abstract HOX genes are frequent targets of chromosomal translocations and retroviral integrations in human and murine acute leukemia, often involving genes at the 5′-end of the HOX clusters. We previously reported that HOX expression patterns in AML were related to prognostic cytogenetic subsets. We also identified a distinct subset of patients with intermediate cytogenetics based on high levels of HOX and FLT3 expression, frequent FLT3 mutations and a low incidence of C/EBPa mutations. Certain cases of T-ALL also have rearrangements of homeodomain genes and some T-ALLs express limited myeloid markers. To further explore the spectrum of homeodomain gene expression, we developed qRT-PCR assays for nearly all clustered HOXA-D genes, selected homeodomain genes on chromosomes often altered in AML, and selected polycomb (Pc) genes, FLT3 and MLL. Altogether, 52 genes were analyzed in 32 AML and T-ALL cell lines. FLT3 expression was confined to a subset of AMLs. HOX11, HOX11L2 and NKX2.5 were expressed only in cases involving rearrangements of these genes. The Pc and MLL genes were uniformly expressed. Among HOX clusters, the frequency of gene expression was HOXA>B>C>D. Genes more highly expressed in the HOXC and D clusters were those at the 5′-ends (e.g., D13, C10). Marked or selective overexpression of individual genes suggests their possible involvement in the disease process, immortalization or differentiation. Examples include EN1 (SUPT1), D13 (MEGA1, B9 (PEER). A hierarchical cluster analysis based on homeodomain genes successfully identified subsets of related cell lines. Thus, the analysis of quantitative HOX expression may provide an important new tool to better understand the biology of acute leukemia.
Title: Homeodomain Expression in AML and T-ALL Cell Lines.
Description:
Abstract HOX genes are frequent targets of chromosomal translocations and retroviral integrations in human and murine acute leukemia, often involving genes at the 5′-end of the HOX clusters.
We previously reported that HOX expression patterns in AML were related to prognostic cytogenetic subsets.
We also identified a distinct subset of patients with intermediate cytogenetics based on high levels of HOX and FLT3 expression, frequent FLT3 mutations and a low incidence of C/EBPa mutations.
Certain cases of T-ALL also have rearrangements of homeodomain genes and some T-ALLs express limited myeloid markers.
To further explore the spectrum of homeodomain gene expression, we developed qRT-PCR assays for nearly all clustered HOXA-D genes, selected homeodomain genes on chromosomes often altered in AML, and selected polycomb (Pc) genes, FLT3 and MLL.
Altogether, 52 genes were analyzed in 32 AML and T-ALL cell lines.
FLT3 expression was confined to a subset of AMLs.
HOX11, HOX11L2 and NKX2.
5 were expressed only in cases involving rearrangements of these genes.
The Pc and MLL genes were uniformly expressed.
Among HOX clusters, the frequency of gene expression was HOXA>B>C>D.
Genes more highly expressed in the HOXC and D clusters were those at the 5′-ends (e.
g.
, D13, C10).
Marked or selective overexpression of individual genes suggests their possible involvement in the disease process, immortalization or differentiation.
Examples include EN1 (SUPT1), D13 (MEGA1, B9 (PEER).
A hierarchical cluster analysis based on homeodomain genes successfully identified subsets of related cell lines.
Thus, the analysis of quantitative HOX expression may provide an important new tool to better understand the biology of acute leukemia.

Related Results

Factors Affecting the Survival of Therapy Related AML/MDS, Secondary AML and De Novo AML
Factors Affecting the Survival of Therapy Related AML/MDS, Secondary AML and De Novo AML
Abstract Introduction: Patients exposed to cytotoxic agents are at a higher risk of developing therapy related AML and MDS (tAML/tMDS), and have poor ...
Venous-Thromboembolism in Elderly Patients with Acute Myeloid Leukemia
Venous-Thromboembolism in Elderly Patients with Acute Myeloid Leukemia
BACKGROUND: Venous-thromboembolism (VTE) is a debilitating condition and is associated with excess mortality. Small, single institution studies suggest that the risk of VTE in acut...
Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?
Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?
Aim: To compare the main features of patients with secondary acute myeloid leukemias (AMLs) after post-myelodysplastic syndrome (AML-post-MDS) or post-myeloproliferative neoplasms ...
Abstract 5120: Surveying the AML surfaceome for novel immunotherapeutic targets
Abstract 5120: Surveying the AML surfaceome for novel immunotherapeutic targets
Abstract Acute myeloid leukemia (AML) therapy requires very intensive chemotherapy/stem cell transplant that cures only 60% of children and 25% of adults with AML. T...
Machine Learning-Based Predictive Modeling Maximizes the Efficacy of mTOR/TP53 Co-Targeting Therapy Against Acute Myeloid Leukemia
Machine Learning-Based Predictive Modeling Maximizes the Efficacy of mTOR/TP53 Co-Targeting Therapy Against Acute Myeloid Leukemia
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that plays a critical role in regulating cell growth, proliferation and survival. The mTOR pathway is often hy...
Chemosensitizing Effect of Fenretinide-Induced NF-κb Inhibition in AML Therapy
Chemosensitizing Effect of Fenretinide-Induced NF-κb Inhibition in AML Therapy
Abstract INTRODUCTION: Acute myeloid leukemia (AML) represents a genetically heterogeneous hematological malignancy and is among top 10 common cancers in China. Thou...

Back to Top